In Navigating Relational Transitions and Antidepressant‑Induced Emotional Blunting , the author delivers a groundbreaking exploration of how modern psychopharmacology reshapes the emotional architecture of human connection. Drawing from clinical research, psychological theory, and lived experience, this work examines the subtle yet devastating relational consequences of Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin‑Norepinephrine Reuptake Inhibitors (SNRIs)-medications that stabilize mood but often flatten the emotional spectrum that sustains intimacy. When antidepressant‑induced emotional blunting (AIEB) enters a relationship, love itself becomes a clinical variable. The book traces how apathy, reduced reinforcement learning, and affective dulling erode the high‑valence emotions that once animated romantic and familial bonds. Through case studies and boundary‑mapping frameworks, it reveals how partners struggle to interpret the sudden shift from passion to polite detachment, and how clinicians can help couples differentiate pharmacological side effects from genuine incompatibility. Far from a condemnation of antidepressants, this text advocates for nuanced understanding-bridging neuroscience and empathy. It offers strategies for maintaining relational integrity amid pharmacological change: communication models, therapeutic interventions, and ethical considerations for practitioners navigating the blurred line between treatment and emotional authenticity. At its core, Navigating Relational Transitions is a call to rehumanize mental‑health discourse. It invites readers-patients, caregivers, and clinicians alike-to confront the paradox of healing that numbs, and to rediscover the possibility of connection beyond chemical equilibrium.